Starpharma Holdings Limited (AU:SPL) has released an update. Starpharma Holdings Limited has announced the results of its reconvened 2024 Annual General Meeting, with Resolution 1 being carried successfully. The company,
Starpharma Holdings Limited (AU:SPL) has released an update. Starpharma Holdings Limited has announced the results of its reconvened 2024 Annual General Meeting, with Resolution 1 being carried successfully. The company,
Starpharma Holdings Limited (AU:SPL) has released an update. Starpharma Holdings Limited is set to reconvene its Annual General Meeting on November 29, 2024, after adjourning the vote on its Remuneration
Starpharma Holdings Limited (AU:SPL) has released an update. Starpharma Holdings Limited announced the results of its 2024 Annual General Meeting, revealing that most resolutions were carried except for the adoption
Starpharma Holdings Limited (AU:SPL) has released an update. Starpharma Holdings Limited, a biotechnology company known for its dendrimer technology, has undergone significant transformation under new CEO Cheryl Maley, focusing on
Starpharma Holdings Limited (AU:SPL) has released an update. Starpharma Holdings Limited’s DEP® SN38 shows promising results in treating advanced colorectal and ovarian cancers, as presented at a recent cancer conference.